All In Biotech

Drug Trial Radar · NCT07085429

Development of Clinical and Biological Database on Bronchial Cancer

Development of a Prospective Monocentric Clinico-Biological Database for Bronchial Cancer

Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

750

Planned (sponsor's estimate)

Start

Nov 25, 2025

Primary completion

Sep 2030

Study completion Sep 2040

Sponsor

Lead sponsor
Institut du Cancer de Montpellier - Val d'AurelleAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical data to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to bronchial cancer.

Conditions

  • Lung Cancer
  • Bronchial Cancer

Interventions

  • Blood and tissue samplingBiological

    Tissue samples (tumor tissue and healthy tissue) frozen and secured in paraffin collected during surgery. During the blood samples taken for diagnosis and / or treatment when possible. Additional samples for research purposes will be carried out, these blood samples will be collected: * before any therapeutic intervention (T1) for a total volume of 36mL, * prior to surgery (T-Surg) for a total volume of 24mL, * at each progression (T2a, b, c…) for a total volume of 24mL, * at the end of follow-up (T3) for a total volume of 24mL.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients who consent to participate in the studyTime frame: through study completion : an average of 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle

    Montpellier, France, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.